GSK3326595
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK3326595, covering 2022-10-25 to 2025-03-10. Get the full timeline:
Most recent: Clinical Trial Update: An Open-label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics and Clinical Activity of GSK3326595 in Participants With Solid Tumors and Non-Hodgkin's Lymphoma [Phase 1]